These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33389881)
21. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177 [TBL] [Abstract][Full Text] [Related]
22. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis. Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834 [TBL] [Abstract][Full Text] [Related]
23. Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer. Mitobe Y; Ikeda K; Sato W; Kodama Y; Naito M; Gotoh N; Miyata K; Kataoka K; Sasaki H; Horie-Inoue K; Inoue S Cancer Sci; 2020 Jul; 111(7):2440-2450. PubMed ID: 32437068 [TBL] [Abstract][Full Text] [Related]
24. LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. Lv M; Xu P; Wu Y; Huang L; Li W; Lv S; Wu X; Zeng X; Shen R; Jia X; Yin Y; Gu Y; Yuan H; Xie H; Fu Z Oncotarget; 2016 Mar; 7(11):13047-59. PubMed ID: 26910840 [TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis. Thakur KK; Kumar A; Banik K; Verma E; Khatoon E; Harsha C; Sethi G; Gupta SC; Kunnumakkara AB J Cell Physiol; 2021 Dec; 236(12):7938-7965. PubMed ID: 34105151 [TBL] [Abstract][Full Text] [Related]
26. The role of FOXC1/FOXCUT/DANCR axis in triple negative breast cancer: a bioinformatics and experimental approach. Kamaliyan Z; Mirfakhraie R; Azizi-Tabesh G; Darbeheshti F; Omranipour R; Ahmadinejad N; Zokaei E; Yassaee VR Mol Biol Rep; 2022 Apr; 49(4):2821-2829. PubMed ID: 35066769 [TBL] [Abstract][Full Text] [Related]
27. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer. Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of long noncoding RNAs in gastric cancer: a meta-analysis. Gao S; Zhao ZY; Wu R; Zhang Y; Zhang ZY Onco Targets Ther; 2018; 11():4877-4891. PubMed ID: 30147339 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis. Gao G; Wang Z; Qu X; Zhang Z BMC Cancer; 2020 Mar; 20(1):179. PubMed ID: 32131780 [TBL] [Abstract][Full Text] [Related]
30. Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring. Zhou Y; Yue Y; Fan S; Jia Q; Ding X Mol Biotechnol; 2021 Dec; 63(12):1093-1102. PubMed ID: 34245439 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2. Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262 [TBL] [Abstract][Full Text] [Related]
32. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. Zheng S; Li M; Miao K; Xu H J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053 [TBL] [Abstract][Full Text] [Related]
33. Long Non-Coding RNA Expression in Laser Micro-Dissected Luminal A and Triple Negative Breast Cancer Tissue Samples-A Pilot Study. Marcu A; Nitusca D; Vaduva A; Baderca F; Cireap N; Coricovac D; Dehelean CA; Seclaman E; Ilina R; Marian C Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33921283 [No Abstract] [Full Text] [Related]
34. Co-expression networks revealed potential core lncRNAs in the triple-negative breast cancer. Yang F; Liu YH; Dong SY; Yao ZH; Lv L; Ma RM; Dai XX; Wang J; Zhang XH; Wang OC Gene; 2016 Oct; 591(2):471-7. PubMed ID: 27380926 [TBL] [Abstract][Full Text] [Related]
35. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer. Yang Q; Fu Y; Wang J; Yang H; Zhang X J Zhejiang Univ Sci B; 2023 Dec; 24(12):1123-1140. PubMed ID: 38057269 [TBL] [Abstract][Full Text] [Related]
36. Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value. Jiang YZ; Liu YR; Xu XE; Jin X; Hu X; Yu KD; Shao ZM Cancer Res; 2016 Apr; 76(8):2105-14. PubMed ID: 26921339 [TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512 [TBL] [Abstract][Full Text] [Related]
38. Revealing the Potential Markers of N(4)-Acetylcytidine through acRIP-seq in Triple-Negative Breast Cancer. Zhang X; Zeng J; Wang J; Yang Z; Gao S; Liu H; Li G; Zhang X; Gu Y; Pang D Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553667 [TBL] [Abstract][Full Text] [Related]
39. Roles and expression profiles of long non-coding RNAs in triple-negative breast cancers. Kong X; Liu W; Kong Y J Cell Mol Med; 2018 Jan; 22(1):390-394. PubMed ID: 28941134 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive Transcriptome Profiling Reveals Multigene Signatures in Triple-Negative Breast Cancer. Liu YR; Jiang YZ; Xu XE; Hu X; Yu KD; Shao ZM Clin Cancer Res; 2016 Apr; 22(7):1653-62. PubMed ID: 26813360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]